Literature DB >> 30944408

Stratifying the effects of SGLT2i.

Irene Fernández-Ruiz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30944408     DOI： 10.1038/s41569-019-0198-x

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  3 in total

1.  Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

Authors:  Eri T Kato; Michael G Silverman; Ofri Mosenzon; Thomas A Zelniker; Avivit Cahn; Remo H M Furtado; Julia Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc P Bonaca; Christian T Ruff; Akshay S Desai; Shinya Goto; Peter A Johansson; Ingrid Gause-Nilsson; Per Johanson; Anna Maria Langkilde; Itamar Raz; Marc S Sabatine; Stephen D Wiviott
Journal:  Circulation       Date:  2019-03-18       Impact factor: 29.690

2.  Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.

Authors:  Remo H M Furtado; Marc P Bonaca; Itamar Raz; Thomas A Zelniker; Ofri Mosenzon; Avivit Cahn; Julia Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Christian T Ruff; Jose C Nicolau; Ingrid A M Gause-Nilsson; Martin Fredriksson; Anna Maria Langkilde; Marc S Sabatine; Stephen D Wiviott
Journal:  Circulation       Date:  2019-03-18       Impact factor: 29.690

Review 3.  Effect of glucose-lowering therapies on heart failure.

Authors:  Michael Nassif; Mikhail Kosiborod
Journal:  Nat Rev Cardiol       Date:  2018-01-25       Impact factor: 32.419
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.